viewRedx Pharma PLC

Redx Pharma extends deadline for takeover discussions

The ‘put up or shut up’ deadline for a bid by a consortium of investors has been extended to 28 February

Redx Pharma Plc - Redx Pharma extends deadline for takeover discussions

Redx Pharma PLC (LON:REDX) has extended discussions over a possible takeover offer to 28 February from 14 February.

In an announcement on Friday afternoon, the drug developer said the ‘put up or shut up’ deadline for a bid by a consortium of investors has been extended for the parties to conclude ongoing discussions.

READ: Redx Pharma unveils second fibrosis drug candidate will enter clinic in the first half of next year

Redx added that it was also in dialogue with shareholders and third-party healthcare specialist investors regarding longer-term funding as well as how to monetise certain assets in its portfolio.

The company said “significant progress” has been made and that it is looking to extend its working capital position beyond the end of March 2020 through short-term debt financing.

Quick facts: Redx Pharma PLC

Price: 14.25 GBX

Market: AIM
Market Cap: £27.08 m


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Redx Pharma PLC named herein, including the promotion by the Company of Redx Pharma PLC in any Content on the Site, the Company receives from...



Morning Report: FTSE 100 rallies as Italians ban short selling

Headlines from the Proactive UK newsroom. The FTSE 100 rallied this morning even though Asian markets suffered more pain overnight.  London’s blue chip index opened around 157 points higher at 5,395 after giving up 639 points yesterday. Italy has introduced a temporary ban on...

2 weeks, 3 days ago

2 min read